viernes, enero 28, 2022
InicioOpiniónPeter McCullough, un eminente cardiólogo, nefrólogo, e inmunólogo, con más de 300...

Peter McCullough, un eminente cardiólogo, nefrólogo, e inmunólogo, con más de 300 publicaciones, convertido en “negacionista bebelejía”

McCullough ha publicado 200 artículos científicos en los últimos tres años en las principales revistas de medicina. No está nada mal para un "negaconista conspiranoico"

Las vueltas que da la vida, Peter McCullough, un reputado cardiólogo que era invitado a dar conferencias por la FDA, la Agencia Europea del Medicamento, la Academia de Ciencias de Nueva York o el Congreso de los EE.UU., se convirtió en un apestado negacionista.

Tanto es así que al otrora insigne galeno, que ha publicado centenares de artículos académicos, le han retirado una publicación científica sin ofrecerle explicación alguna. A ojos de los guardianes del relato covidiótico, McCullough ha pasado de ser un médico de referencia en sus especialidades, a un bebedor compulsivo de hipoclorito de sodio, un hechicero indigno de ser siquiera escuchado.

La opinión de McCullough (muy sintetizada) es que ha sido un error confiar toda la estrategia de la lucha contra la pandemia tan solo en las substancias ARN mensajero y adenovirus que se administran como vacunas. Este cardiólogo afirma que se ha relegado e incluso prohibido el uso de tratamientos terapéuticos eficaces, apostándolo todo a una sola carta, las “vacunas”; substancias que se administran de forma discrecional y masiva a pesar de las evidencias sobre su cada vez más escasa efectividad y su probada capacidad de causar efectos adversos muy por encima de los que causan las vacunas de verdad.

Obviamente esta forma de pensar pone muy tristes a los fabricantes de estas “vacunas“. Y además McCullough va y demuestra mediante un estudio que lo que dice se refleja en la realidad y se substancia en los números; eso incluso les hace llorar a muchos. Ese es el planteamiento tan negacionista que le ha granjeado la sentencia de hechicería.

Los mismos guardianes de las verdades científico-políticas que en cada momento toque sostener, con el patrocinio de las principales farmacéuticas, son los que repiten con insistencia que todos los médicos, virólogos, inmunólogos y científicos opinan igual. Solo les falta añadir “y que se atrevan a no hacerlo”.

Con este consenso médico-científico cimentado en el miedo y en la ley del silencio, y engrasado por un abundante flujo de efectivo, ocurre algo parecido a lo que sucede con el feminismo o con el colectivo alfabético (LGBTIQ+). Si a pesar de creerte mujer no sostienes las verdades que el feminismo te ha revelado, so zorra, entonces no eres mujer. Si a pesar de tener más pluma que un pavo real no estás de acuerdo con los postulados del colectivo alfabético que dirige –por tu bien– tus destinos, no eres homosexual, eres una maricona mala y además homófoba.

Para algo están los corrales, para estar calentito y balar todos juntos y en sintonía la misma canción. Si cantas otra copla es porque no eres mujer, no eres homosexual y no eres médico de verdad.

Además los médicos buenos y dóciles que abogan por la obligatoriedad de inyectar substancias poco eficaces y demostradamente peligrosas, o por la coerción o el desprecio hacia quiénes no lo hagan, si se lo montan bien podrán hacer sus muy bien pagados bolos patrocinados por los fabricantes de esas pócimas que tanto defienden. En el artículo que enlazo bajo este párrafo te presento a Federico Martinón, un ejemplo de galeno bien mandado que publicó la siguiente frase en un artículo de La Voz de Galicia: Si hemos conseguido que la gente circule por la playa o haga deporte al aire libre con mascarilla, sin evidencias científicas que demuestren claramente el beneficio objetivo de dichas medidas, parece bastante más sencillo conseguir que la gente se vacune con los datos abrumadores que tenemos demostrando su beneficio”. Una frase digna de un amaestrador de perros y no de un médico pediatra como es este cabroncete.

Robert Malone, otro conspicuo ex científico a ojos de los hacedores del “consenso”, etiquetado también como deglutidor de lejía por la Santa Inquisición Vacunóloga, escribía en Twitterstán que en toda su carrera científica jamás había visto que se retirara un artículo de esa manera (refiriéndose al de McCullough).

Malone es hoy considerado por los apóstoles del consenso como un nigromante embaucador. Su carrera como científico no debe ser tenida en cuenta porque al parecer Malone se ha pasado al Lado Oscuro de la Fuerza. Aunque se trate de un virólogo de prestigio, que además es el padre y uno de los pioneros en el uso de la tecnología de ARN mensajero, sus opiniones son catalogadas como brujería. El tipo cuyas investigaciones condujeron a la creación de estas substancias, va y nos advierte de que las mismas se están empleando mal, así que se le bautiza como negacionista y a por el siguiente.

Mientras tanto mucha gente traga. Prefieren creerse al perioLISTO de turno que no da noticias sino que se limita a la REPETICIÓN DE MANTRAS Y CONSIGNAS. Si la tele no cuenta determinadas cosas debe ser porque esas cosas o no existen o no merecen la pena ser contadas ¿Para qué informar de un cardiólogo eminente diciendo cosas que contradicen la versión oficial? Al fin y al cabo tan solo son insignes profesionales advirtiéndonos de riesgos, nada que deba preocupar a una población desnortada y embaucada a partes iguales.

Todo está en orden, no hay nada que ver aquí, circulen y sepan que las vacunas salvan vidas, lo han dicho en la tele. Solo la gente muy rara y fanática, que además piensan que la Tierra es plana y que no existieron los dinosaurios, sostiene que estas maravillosas vacunas, que solo funcionarán, tal vez, con el 130% de la población cuádruplemente inyectada, son algo peor que un fraude. Para poder sostener este guiñol que se descuadernaría en muy poco tiempo si se permitiera que hubiera un verdadero debate científico y estadístico son necesarias dos cosas: dinero y tontos, y parece que hay abundancia de ambas.

Para poder sostener este guiñol, que se descuadernaría en muy poco tiempo si se hubiera permitido un verdadero debate científico y estadístico, son necesarias dos cosas:

1.- Dinero para comprar voluntades, ablandar conciencias, entretener tontos y fabricar tontos nuevos.

2.- Tontos capaces de creerse que todos los que se oponen a la verdad oficial son antivacunas, negacionistas o personajes fácilmente atacables como Miguel Bosé. Da igual que estar en contra de ciertas substancias no sea estar en contra de las vacunas, da igual que llamar negacionista a alguien sin especificar qué es lo que esa persona niega sea aberrante.

McCullough es un referente en el campo de la cardiología, co-publicó junto con la doctora Jessica Rose, un artículo en la revista médica “Current Problems in Cardiology” (problemas actuales en cardiología) recogido en la web Science Direct en el que se analizaban las cifras oficiales del VAERS (Vaccine Adverse Event Reporting System o Sistema de Reporte de Efectos Adversos a las Vacunas) y encontraban una incidencia espectacularmente grave de cuadros de miocarditis, muchos muy severos o incluso mortales, entre personas inyectadas con las substancias covid.

La prevalencia de estos cuadros de miocarditis era mayor entre la población más joven y significativamente más alta entre los niños y jóvenes varones.

El editor de la revista retiró el artículo sin ofrecer ninguna explicación ¿Será porque McCullough no es un especialista en cardiología y ha estado engañando a todo el mundo durante décadas?

Evidentemente no. Se trata de silenciar a las voces que hacen algo que está en la misma base de la ciencia y de su método: OBSERVAR LA REALIDAD. Pero cuando la realidad no sirve para empujar el “relato” consagrado como único hay que tapar esa realidad y escarniar al observador chivato. Los que blasfeman contra la ciencia anunciando la existencia de un consenso científico inexistente y rehúyen el debate no son solo cobardes, que por supuesto lo son, sino algo aún peor, son traidores a la lógica, a la libertad y a la misma Humanidad.

El dinero narcotiza conciencias y el poder anestesia el sentido de moralidad. Pasaremos lista. Ahí lo dejo. Hay que machacar al contrario sin hacer que la gente piense demasiado, hacer el chiste fácil y dar consignas masticaditas, o mejor memes, que eviten que la gente profundice en la realidad.

El trabajo de los medios, paniaguados con publicidad institucional y de empresas interesadas en empujar el “relato-covid” oficial, es impedir que la población se entere de que hay innumerables personalidades de todos los ámbitos de la ciencia, la sociedad y la política que tienen cosas importantes que decir distintas del catecismo oficial, que el consenso no existe y que los números cantan verdades incómodas.

McCullough ha publicado 200 artículos en los últimos tres años “solamente”… y varios cientos más a lo largo de su trayectoria profesional. No está mal para tratarse de un “negacionista”.

Ahí os dejo un listado de enlaces a los trabajos académicos y científicos del hechicero:

“The American Journal of Medicine”, “The American Journal of Cardiology”, “Journal of Hypertension”, “The Lancet” o “Nature” entre otras muchas revistas médicas han publicado los trabajos de este especialista en Medicina Interna, Cardiología, Nefrología y Epidemiología. Pero su brillante trayectoria profesional no le ha servido de nada una vez que ha dicho cosas “feas” e incómodas y ha sido sentenciado y relegado a la categoría de curandero charlatán por un sanedrín de periodistas, ciberdictadores y médicos y científicos pastueños. Aquí algunos enlaces para que te entretengas (nombre del artículo, número de revisiones por parte de pares y año de publicación):

SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort studyGS Collaborative, COVIDSurg CollaborativeAnaesthesia 77 (1), 2822022
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc …S Verma, NK Dhingra, J Butler, SD Anker, JP Ferreira, G Filippatos, …The Lancet Diabetes & Endocrinology12021
TAMIS management of large peritoneal entry for recurrent rectal polyp: A video vignetteM Flanagan, JM Ryan, T Connelly, F Cooke, P McCullough, P NearyColorectal Disease2021
Internal Hernia Through Petersen’s Defect 13 Years Post Gastrectomy+ Roux‐En‐YB Rigney, M Flanagan, P McCullough, P Neary, F CookeColorectal Disease2021
Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future DiseaseK McKernan, AM Kyriakopoulos, PA McCulloughOSF Preprints12021
Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort studyCOVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, …Anaesthesia 76 (11), 1454-146452021
Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients …KU Eckardt, R Agarwal, YM Farag, AG Jardine, Z Khawaja, MJ Koury, …Nephrology Dialysis Transplantation 36 (11), 2039-204882021
Haematological splenectomy in University Hospital Waterford: A 10‐year audit and video vignetteJM Ryan, T Connelly, A Bryan, P McCullough, P Neary, F CookeColorectal Disease2021
Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on HemodialysisBA Koplan, WC Winkelmayer, AI Costea, P Roy-Chaudhury, JA Tumlin, …Kidney International Reports12021
Laparoscopic‐assisted resection of small bowel gastrointestinal stromal tumours–A video vignetteJM Ryan, R Hill, M Flanagan, P McCullough, F Cooke, P NearyColorectal Disease2021
A Report on Myocarditis Adverse Events in the US Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological ProductsJ Rose, PA McCulloughCurrent problems in cardiology12021
Role of hydroxychloroquine in multidrug treatment of COVID-19PA McCullough, RB Stricker, HA RischReviews in Cardiovascular Medicine 22 (3), 545-5462021
Performance of crisis standards of care guidelines in a cohort of critically ill COVID-19 patients in the United StatesJL Jezmir, M Bharadwaj, A Chaitoff, B Diephuis, CP Crowley, SP Kishore, …Cell Reports Medicine 2 (9), 10037622021
Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19AD Santin, DE Scheim, PA McCullough, M Yagisawa, TJ BorodyNew microbes and new infections 43, 10092492021
Mortality and guideline‐directed medical therapy in real‐world heart failure patients with reduced ejection fractionPA McCullough, HS Mehta, CM Barker, J Van Houten, S Mollenkopf, …Clinical Cardiology 44 (9), 1192-11982021
Synthetic mRNAs; Their Analogue Caps and Contribution to DiseaseAM Kyriakopoulos, PA McCulloughDiseases 9 (3), 5712021
Gallstone ileus in an elderly orthopaedic patient managed with enterolithotomy: A video vignette.JM Ryan, M Flanagan, T Connelly, F Cooke, P McCullough, P NearyColorectal Disease: the Official Journal of the Association of …2021
Impact of renin–angiotensin–aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestationsA Palazzuoli, KM Tecson, PA McCulloughJournal of Hypertension 39 (8), 1725-17262021
Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residentsPE Alexander, R Armstrong, G Fareed, J Lotus, R Oskoui, C Prodromos, …Medical hypotheses 153, 11062252021
Pulmonary Tuberculosis Coexisting with Lung Adenocarcinoma ReplyPA McCulloughAMERICAN JOURNAL OF MEDICINE 134 (7), E440-E4412021
Nomenclature for Kidney Function from KDIGO: Shortcomings of Terminology OversimplificationA Palazzuoli, KM Tecson, C Ronco, PA McCulloughCardiorenal Medicine, 1-42021
Clinical outcomes and response to vericiguat according to index heart failure event: insights from the VICTORIA trialCSP Lam, A Giczewska, K Sliwa, F Edelmann, J Refsgaard, E Bocchi, …Jama Cardiology 6 (6), 706-71292021
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort studyCOVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, …Anaesthesia 76 (6), 748-7581272021
Phosphate control: The next frontier in dialysis cardiovascular mortalityPA McCulloughCardioRenal Med 11 (3), 123-13212021
Healthcare utilization and guideline-directed medical therapy in heart failure patients with reduced ejection fractionPA McCullough, HS Mehta, CM Barker, JV Houten, S Mollenkopf, …Journal of comparative effectiveness research 10 (14), 1055-10632021
Nomenclature in nephrology: preserving ‘renal’and ‘nephro’in the glossary of kidney health and diseaseK Kalantar-Zadeh, PA McCullough, SK Agarwal, S Beddhu, M Boaz, …Journal of nephrology 34 (3), 639-64852021
SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developersR Bruno, PA Mccullough, TFI Vila, A Henrion-Caude, T García-Gasca, …Authorea Preprints2021
Cardio-nephrology from the point of view of the cardiologist: no more agree to disagree—getting to “yes” for every patientA Burlacu, PA McCullough, A CovicClinical Kidney Journal22021
Six-Month Outcomes for COVID-19 Negative Patients with Acute Myocardial Infarction Before versus During the COVID-19 PandemicA Aldujeli, A Hamadeh, KM Tecson, Z Krivickas, L Maciulevicius, …The American Journal of Cardiology 147, 16-2242021
MORTALITY AND GUIDELINE DIRECTED MEDICAL THERAPY IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION: EVIDENCE FROM REAL WORLD DATAPA McCullough, H Mehta, C Barker, J Van Houten, S Mollenkopf, …Journal of the American College of Cardiology 77 (18_Supplement_1), 670-6702021
Comments on the Pathophysiological Basis and Rationale for Early Treatment of COVID-19 ReplyPA McCulloughAMERICAN JOURNAL OF MEDICINE 134 (5), E346-E3472021
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: design and baseline characteristicsGM Chertow, PE Pergola, R Agarwal, GA Block, YMK Farag, AG Jardine, …American heart journal 235, 1-1142021
Vadadustat in patients with anemia and non–dialysis-dependent CKDGM Chertow, PE Pergola, YMK Farag, R Agarwal, S Arnold, G Bako, …New England Journal of Medicine 384 (17), 1589-1600222021
Safety and efficacy of vadadustat for anemia in patients undergoing dialysisKU Eckardt, R Agarwal, A Aswad, A Awad, GA Block, MR Bacci, …New England Journal of Medicine 384 (17), 1601-1612212021
Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney DiseaseJH Ishida, C Chauhan, B Gillespie, K Gruchalla, PA McCullough, S Quella, …Clinical Journal of the American Society of Nephrology2021
Effect of combined renin angiotensin aldosterone inhibitors and diuretic treatment among patients hospitalized with SARS-CoV-2 Infection COVID-19A Palazzuoli, KM Tecson, M Vicenzi, F D’Ascenzo, GM De Ferrari, …2021
Measuring the Variation in the Prevention and Treatment of CI-AKI Among Interventional CardiologistsC Valdenor, PA McCullough, D Paculdo, MC Acelajado, JR Dahlen, …Current Problems in Cardiology, 1008512021
Sore Mouth ReplyPA McCulloughAMERICAN JOURNAL OF MEDICINE 134 (4)2021
Anemia of cardiorenal syndromePA McCulloughKidney International Supplements 11 (1), 35-4512021
Comparison of Survival in Patients With Clinically Significant Tricuspid Regurgitation With and Without Heart Failure (From the Optum Integrated File)CM Barker, DP Cork, PA McCullough, HS Mehta, J Van Houten, …The American Journal of Cardiology 144, 125-13012021
SARS-CoV-2 infection and the COVID-19 pandemic: a call to action for therapy and interventions to resolve the crisis of hospitalization, death, and handle the aftermathPA McCullough, K VijayReviews in cardiovascular medicine 22 (1), 9-1022021
Ambulatory Worsening of Renal Function in Heart Failure With Preserved Ejection FractionPA McCullough, G Rahimi, KM TecsonJournal of the American College of Cardiology 77 (9), 1222-12242021
Role of endothelial cell receptors in the context of SARS-CoV-2 infection (COVID-19)J Zhang, KM Tecson, PA McCulloughBaylor University Medical Center Proceedings 34 (2), 262-26812021
Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A Comment ReplyPA McCulloughAMERICAN JOURNAL OF MEDICINE 134 (3), E222-E2232021
Role of Ischemic Heart Disease in Major Adverse Renal and Cardiac Events Among Individuals With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial)G Rahimi, KM Tecson, O Elsaid, PA McCulloughThe American Journal of Cardiology 142, 91-9612021
Screening for SARS-CoV-2 via PCR and serological testing in asymptomatic healthcare workersT Safder, PA McCullough, KR Wheelan, G Rahimi, S Zurawski, …Baylor University Medical Center Proceedings, 1-512021
Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United StatesJE Flythe, MM Assimon, MJ Tugman, EH Chang, S Gupta, J Shah, …American Journal of Kidney Diseases 77 (2), 190-203. e1802021
Early ambulatory multidrug therapy reduces hospitalization and death in high-risk patients with SARS-CoV-2 (COVID-19)B Procter, C Ross, V Pickard, E Smith, C Hanson, PA McCulloughAuthorea Preprints92021
Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemicA Palazzuoli, G Ruocco, KM Tecson, PA McCulloughHeart Failure Reviews, 1-712021
Discordance between estimated and measured changes in plasma volume among patients with acute heart failureJS Swolinsky, E Tuvshinbat, DM Leistner, F Edelmann, F Knebel, …ESC heart failure2021
Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19S Gupta, W Wang, SS Hayek, L Chan, KS Mathews, ML Melamed, …JAMA internal medicine 181 (1), 41-512242021
Association between delayed revascularization during the covid-19 pandemic and rates of post myocardial infarction heart failure hospitalizationsA Aldujeli, A Hamadeh, KM Tecson, Ž Krivickas, L Maciulevičius, …Heart Failure 2021 & [8th] World Congress on Acute Heart Failure: 29 June-01 …2021
Major Adverse Renal and Cardiovascular Events following Intra-Arterial Contrast Media Administration in Hospitalized Patients with Comorbid ConditionsP McCullough, CS Ng, M Ryan, ER Baker, R MehtaCardiorenal medicine 11 (4), 193-1992021
Effectiveness of Ivermectin-Based Multidrug Therapy in Severe Hypoxic Ambulatory COVID-19 PatientsS Hazan, S Dave, AW Gunaratne, S Dolai, PA McCullough, R Clancy, …medRxiv32021
Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failureJS Swolinsky, NP Nerger, DM Leistner, F Edelmann, F Knebel, …ESC Heart Failure12021
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure: invasive hemodynamic parameters and clinical outcomes.KB Lo, HM Toroghi, G Salacup, J Jiang, R Bhargav, E Quintero, …MedReviews, LLC 22 (1), 19932021
Early Multidrug Outpatient Treatment of SARS-CoV-2 Infection (COVID-19) and Reduced Mortality Among Nursing Home ResidentsPE Alexander, R Armstrong, G Fareed, K Gill, J Lotus, R Oskoui, …medRxiv2021
Regarding:“Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019”PA McCulloughAnnals of Medicine 53 (1), 286-28612021
The Low-Density Lipoprotein Cholesterol Hypothesis: An UpdateR Rengarajan, KM Tecson, PA McCulloughTherapeutic Lipidology, 121-1382021
Implications of Chronic Kidney Disease on the Epidemiology of Cardiovascular DiseasePA McCullough, AY KlugerTextbook of Cardiorenal Medicine, 1-52021
Novel Biomarkers of Chronic Cardiorenal DiseasePA McCulloughTextbook of Cardiorenal Medicine, 227-2332021
Type 2 Cardiorenal SyndromeN Rocha, PA McCulloughTextbook of Cardiorenal Medicine, 75-942021
Textbook of Cardiorenal MedicinePA McCullough, C RoncoSpringer2021
Pathophysiological basis and rationale for early outpatient treatment of SARS-CoV-2 (COVID-19) infectionPA McCullough, RJ Kelly, G Ruocco, E Lerma, J Tumlin, KR Wheelan, …The American journal of medicine 134 (1), 16-22872021
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative …SD Roger, PT Lavin, EV Lerma, PA McCullough, J Butler, BS Spinowitz, …Nephrology Dialysis Transplantation 36 (1), 137-150182021
Class effects of SGLT2 inhibitors on cardiorenal outcomesAY KlugerTextbook of Cardiorenal Medicine, 279-294892021
Early multidrug regimens in new potentially fatal medical problemsPA McCullough, R OskouiReviews in cardiovascular medicine 21 (4), 507-50842020
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infectionBC Procter, C Ross, V Pickard, E Smith, C Hanson, PA McCulloughReviews in cardiovascular medicine 21 (4), 611-614262020
Mortality risk assessment using CHA (2) DS (2)-VASc scores in patients hospitalized with coronavirus disease 2019 infectionG Ruocco, PA McCullough, KM Tecson, M Mancone, GM De Ferrari, …The American Journal of Cardiology 137, 111-117162020
The Plasma Metabolome is Significantly Altered in HypercholesterolemiaT Bottiglieri, E Arning, KM Tecson, PA McCulloughCIRCULATION RESEARCH 127 (12), E279-E2792020
265 Incidence, determinants and prognostic relevance of HS-troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patientsL Arcari, M Luciano, L Cacciotti, MB Musumeci, V Spuntarelli, E Pistella, …European Heart Journal Supplements 22 (Supplement_N), N65-N792020
Delays in presentation in patients with acute myocardial infarction during the COVID-19 pandemicA Aldujeli, A Hamadeh, K Briedis, KM Tecson, J Rutland, Z Krivickas, …Cardiology Research 11 (6), 386242020
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysisKB Lo, R Bhargav, G Salacup, J Pelayo, J Albano, PA McCullough, …Expert Review of Cardiovascular Therapy 18 (12), 919-930212020
Acute coronary syndromes in the peri‐operative period after kidney transplantation in United StatesA Goyal, KB Lo, K Chatterjee, RO Mathew, PA McCullough, S Bangalore, …Clinical Transplantation 34 (12), e1408322020
Antecedent Administration of Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID‐19 SyndromeA Palazzuoli, M Mancone, GM De Ferrari, G Forleo, GG Secco, …Journal of the American Heart Association 9 (22), e017364202020
Favipiravir and the need for early ambulatory treatment of SARS-CoV-2 infection (COVID-19)PA McCulloughAntimicrobial Agents and Chemotherapy 64 (12), e02017-20242020
Relation of Transthoracic Echocardiographic Aortic Regurgitation to Pressure Half-time and All-Cause Mortality………………………………… 113 Jordan B. Strom, Eli V …CA Tsao, WJ Manning, P Galazka, R Jain, L Muthukumar, H Sanders, …The American Journal of Cardiology 1352020
Ventricular fibrillation storm in coronavirus 2019O Elsaid, PA McCullough, KM Tecson, RS Williams, A YoonThe American Journal of Cardiology 135, 177-180162020
Factors associated with death in critically ill patients with coronavirus disease 2019 in the USS Gupta, SS Hayek, W Wang, L Chan, KS Mathews, ML Melamed, …JAMA internal medicine 180 (11), 1436-14475062020
Outcomes of critically ill solid organ transplant patients with COVID‐19 in the United StatesMZ Molnar, A Bhalla, A Azhar, M Tsujita, M Talwar, V Balaraman, A Sodhi, …American Journal of Transplantation 20 (11), 3061-3071712020
A novel strategy to prevent contrast nephropathy:“Continuous hemodiafiltration”PA McCullough, JA GoldsteinCatheterization and Cardiovascular Interventions 96 (6), 1182-11832020
TCT CONNECT-213 Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic TherapyA Hamadeh, A Aldujeli, K Briedis, K Tecson, JS Sanchez, M Al Dujeili, …Journal of the American College of Cardiology 76 (17 Supplement S), B89-B902020
Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: a scientific statement from the American Heart AssociationJ Rangaswami, V Bhalla, IH de Boer, A Staruschenko, JA Sharp, …Circulation 142 (17), e265-e286432020
COVID-19-associated systemic thromboembolism: a case report and review of the literatureP Mahajan, B Dass, N Radhakrishnan, PA McCulloughCardiorenal medicine, 1-8132020
Healthcare utilization in clinically significant tricuspid regurgitation patients with and without heart failureCM Barker, DP Cork, PA McCullough, HS Mehta, JV Houten, …Journal of Comparative Effectiveness Research 10 (1), 29-372020
Current overview on hypercoagulability in COVID-19N Singhania, S Bansal, DP Nimmatoori, AA Ejaz, PA McCullough, …American Journal of Cardiovascular Drugs 20 (5), 393-4031092020
Ventricular septal myectomy for the treatment of left ventricular outflow tract obstruction due to Fabry diseaseB Raju, CS Roberts, M Sathyamoorthy, R Schiffman, C Swift, …The American Journal of Cardiology 132, 160-16412020
Usefulness of coronary angiography in patients with left atrial myxomaCE Velasco, NP Suarez, CP Roullard, PA McCullough, WC RobertsBaylor University Medical Center Proceedings 33 (4), 529-5312020
Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathyJ Zhang, KM Tecson, PA McCulloughReviews in cardiovascular medicine 21 (3), 315-319682020
Vitamin D deficiency in association with endothelial dysfunction: Implications for patients with COVID-19J Zhang, PA McCullough, KM TecsonReviews in cardiovascular medicine 21 (3), 339-344232020
Characteristics and outcomes in patients presenting with COVID-19 and ST-segment elevation myocardial infarctionA Hamadeh, A Aldujeli, K Briedis, KM Tecson, J Sanz-Sánchez, …The American journal of cardiology 131, 1-6492020
Inpatient mortality according to level of respiratory support received for severe acute respiratory syndrome coronavirus 2 (Coronavirus Disease 2019) infection: a prospective …A Palazzuoli, F Ruberto, GM De Ferrari, G Forleo, GG Secco, GM Ruocco, …Critical Care Explorations 2 (9)42020
Impact of mitral regurgitation on cardiovascular hospitalization and death in newly diagnosed heart failure patientsDP Cork, PA McCullough, HS Mehta, CM Barker, C Gunnarsson, …ESC heart failure 7 (4), 1502-150922020
Analysing risk in heart failure: a K alium checkRT Glenister, PA McCulloughEuropean journal of heart failure 22 (8), 1412-14142020
Meta-analysis of outcomes of patients with COVID-19 infection with versus without gastrointestinal symptomsF Gul, KB Lo, J Peterson, PA McCullough, A Goyal, J RangaswamiBaylor University Medical Center Proceedings 33 (3), 366-369112020
Disconnect between community testing and hospitalization for SARS-CoV-2 (COVID-19) infectionPA McCullough, J ArunthamakunBaylor University Medical Center Proceedings 33 (3), 481-48152020
SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically illA Kazory, C Ronco, PA McCulloughBaylor University Medical Center Proceedings 33 (3), 370-375392020
Early Statin Use and Recurrent Major Adverse Cardiovascular Events: A Multicenter StudyK Tecson, A Kluger, A Cassidy-Bushrow, B Liu, C Coleman, L Jones, …Journal of Clinical Lipidology 14 (4), 5612020
Considerations for management of acute coronary syndromes during the SARS-CoV-2 (COVID-19) pandemicK Briedis, A Aldujeli, M Aldujeili, K Briede, R Zaliunas, A Hamadeh, …The American journal of cardiology72020
APPLICATION OF A RISK MITIGATION STRATEGY TO PREVENT EXCESS CARDIOVASCULAR RISK IN PULMONARY HYPERTENSION: LARIAT STUDYRJ White, M Chakinala, M Chin, J Feldman, A Goldsberry, P McCullough, …NEPHROLOGY DIALYSIS TRANSPLANTATION 35, 533-5332020
P0229 APPLICATION OF A RISK MITIGATION STRATEGY TO PREVENT EXCESS CARDIOVASCULAR RISK IN PULMONARY HYPERTENSION: LARIAT STUDYRJ White, M Chakinala, M Chin, J Feldman, A Goldsberry, P McCullough, …Nephrology Dialysis Transplantation 35 (Supplement_3), gfaa142. P02292020
The economic impact of clinically significant tricuspid regurgitation in a large, administrative claims databaseDP Cork, PA McCullough, HS Mehta, CM Barker, J Van Houten, …Journal of medical economics 23 (5), 521-52842020
Mediators of the Effects of Canagliflozin on Heart Failure: Central Role of the Cardiorenal AxisKB Lo, PA McCullough, J RangaswamiHeart Failure 8 (5), 426-42612020
Antihypertensive drugs and risk of COVID-19?KB Lo, PA McCullough, J RangaswamiThe Lancet. Respiratory Medicine 8 (5), e29202020
Prevention Guidelines as Failed Minimal Standards of CarePA McCulloughThe American journal of cardiology 125 (9), 1441-144212020
Readers’ Comments: Aspirin and/or Other Antiplatelet Agents for the Prevention of Infective EndocarditisJE MadiasThe American journal of cardiology 125 (9), 14502020
Impact of durable ventricular assist device support on outcomes of patients with congenital heart disease waiting for heart transplantA Cedars, KM Tecson, AN Zaidi, A Lorts, PA McCulloughASAIO Journal 66 (5), 513-51962020
Contrast induced acute kidney injury in interventional cardiology: an update and key guidance for cliniciansF Ronco, G Tarantini, PA McCulloughReviews in cardiovascular medicine 21 (1), 9-23122020
Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort studyA Agrawal, HUH Virk, I Riaz, D Jain, B Tripathi, C Krittanawong, …Reviews in cardiovascular medicine 21 (1), 123-12742020
MEDICAL THERAPY IN PATIENTS WITH FUNCTIONAL MITRAL REGURGITATION: ARE PATIENTS OPTIMIZED IN THE REAL WORLD?H Mehta, P McCullough, DP Cork, C Barker, J Van Houten, C Gunnarsson, …Journal of the American College of Cardiology 75 (11_Supplement_1), 1322-13222020
SURVIVAL IN CLINICALLY SIGNIFICANT TRICUSPID REGURGITATION PATIENTS WITH AND WITHOUT HEART FAILURE: EVIDENCE FROM OPTUM’S INTEGRATED DATABASESCM Barker, DP Cork, H Mehta, P McCullough, W Irish, J Van Houten, …Journal of the American College of Cardiology 75 (11_Supplement_1), 1319-13192020
Limitations of transoesophageal echocardiogram in acute ischaemic strokeZP Rosol, KF Kopecky, BR Minehart, KM Tecson, A Vasudevan, …Open heart 7 (1), e00117612020
Prophylactic biological mesh reinforcement versus standard closure of stoma site (ROCSS): a multicentre, randomised controlled trialA Bhangu, D Nepogodiev, N Ives, L Magill, J Glasbey, C Forde, …The Lancet 395 (10222), 417-426132020
Circulating plasma dipeptidyl dipeptidase 3 and the prognosis of cardiogenic shockB Raju, PA McCulloughEuropean journal of heart failure 22 (2), 287-28912020
Mortality risk assessment using CHA (2) DS (2)-VASC scores in patients hospitalized with COVID-19 infectionG Ruocco, P Mccullough, K Tecson, M Mancone, GM De Ferrari, …European Heart Journal Supplements, N77-N772020
Kidney Disease in the Cardiac Catheterization Laboratory: A Practical ApproachJ Rangaswami, EV Lerma, PA McCulloughSpringer Nature2020
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)PA McCullough, PE Alexander, R Armstrong, C Arvinte, AF Bain, …Reviews in cardiovascular medicine 21 (4), 517792020
Randomized controlled trials of early ambulatory hydroxychloroquine in the prevention of COVID-19 infection, hospitalization, and death: meta-analysisJA Ladapo, JE McKinnon, PA McCullough, H RischMedRxiv212020
Fulminant acute kidney injury in a young patient with novel coronavirus 2019A Gopalakrishnan, A Mossaid, KB Lo, V Vasudevan, PA McCullough, …Cardiorenal medicine 10 (4), 217-222172020
Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infectionPA McCullough, J Eidt, J Rangaswami, E Lerma, J Tumlin, K Wheelan, …Reviews in cardiovascular medicine 21 (1), 1332020
Renal and cardiovascular effects of sodium glucose co-transporter 2 inhibitors in patients with type 2 diabetes and chronic kidney disease: perspectives on the Canagliflozin …MR Weir, PA McCullough, JB Buse, J AndersonAmerican journal of nephrology 51 (4), 276-28872020
Benefits and risks of continuing angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and mineralocorticoid receptor antagonists during …E Oliveros, ET Oni, A Shahzad, AY Kluger, KB Lo, J Rangaswami, …Cardiorenal medicine 10 (2), 69-84162020
The effects of SGLT2 inhibitors on cardiovascular and renal outcomes in diabetic patients: a systematic review and meta-analysisKB Lo, F Gul, P Ram, AY Kluger, KM Tecson, PA McCullough, …Cardiorenal medicine 10 (1), 1-10482020
Cardiovascular Disease and Chronic Kidney DiseaseJ Rangaswami, PA McCulloughChronic Renal Disease, 337-3532020
Cardiorenal syndromeS Soman, C Chitturi12020
Alterations in Doppler-derived renal venous stasis index during decompensation of right heart failure and fluid overload in a patient with pulmonary hypertensionF Husain-Syed, HW Birk, K Tello, MJ Richter, C Ronco, PA McCullough, …Reviews in cardiovascular medicine 20 (4), 263-26622019
Arrhythmias and Conduction DisturbancesFPLA Appendage, JP Pouru, S Jaakkola, J Lund, F Biancari, A Saraste, …The American Journal of Cardiology 124 (12)2019
The CatLet score: a new coronary angiographic scoring tool accommodating the variable coronary anatomy for the first timeMX Xu, RL Teng, TD Ruddy, P Schoenhagen, T Bartel, R Di Bartolomeo, …Journal of thoracic disease 11 (12), 519942019
Doppler‐derived renal venous stasis index in the prognosis of right heart failureF Husain‐Syed, HW Birk, C Ronco, T Schörmann, K Tello, MJ Richter, …Journal of the American Heart Association 8 (21), e013584252019
First and recurrent events after percutaneous coronary intervention: implications for survival analysesA Vasudevan, JW Choi, GA Feghali, AY Kluger, SR Lander, KM Tecson, …Scandinavian Cardiovascular Journal 53 (6), 299-30412019
PCV116 USING ADMINISTRATIVE CLAIMS DATA TO ESTIMATE THERAPEUTIC INTENSITY IN MEDICALLY MANAGED HEART FAILURE PATIENTSJ Van Houten, PA McCullough, H Mehta, C Barker, D Cork, C Gunnarsson, …Value in Health 22, S5632019
The Economic Impact of Mitral Regurgitation on Patients With Medically Managed Heart FailurePA McCullough, HS Mehta, CM Barker, DP Cork, C Gunnarsson, …The American journal of cardiology 124 (8), 1226-12312019
TCT-432 The Economic Impact of Clinically Significant Tricuspid RegurgitationP Verta, P McCullough, C Barker, D Cork, H Mehta, C Gunnarsson, …Journal of the American College of Cardiology 74 (13S), B427-B4272019
Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved …SD Anker, J Butler, GS Filippatos, W Jamal, A Salsali, J Schnee, K Kimura, …European journal of heart failure 21 (10), 1279-12871332019
Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced …M Packer, J Butler, GS Filippatos, W Jamal, A Salsali, J Schnee, K Kimura, …European journal of heart failure 21 (10), 1270-1278772019
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney diseaseP Rossing, GA Block, MP Chin, A Goldsberry, HJL Heerspink, …Kidney international 96 (4), 1030-1036162019
Continuation of chronic heart failure therapies during heart failure hospitalization-a reviewG Singhania, AA Ejaz, PA McCullough, AY Kluger, S Balamuthusamy, …IMR Press182019
The healthcare burden of disease progression in medicare patients with functional mitral regurgitationPA McCullough, HS Mehta, DP Cork, CM Barker, C Gunnarsson, …Journal of medical economics 22 (9), 909-91622019
The Promise of next generation sequencing micro RNA for the discovery of new targets in contrast induced acute kidney injuryA Haq, PA McCulloughAnnals of translational medicine 7 (18)2019
Cardiovascular disease care fragmentation in kidney transplantation: a call for actionJ Rangaswami, S Bangalore, B Kaplan, KA Birdwell, AC Wiseman, …Kidney international 96 (3), 568-57132019
Event dependence in the analysis of cardiovascular readmissions postpercutaneous coronary interventionA Vasudevan, JW Choi, GA Feghali, SR Lander, L Jialiang, JM Schussler, …Journal of Investigative Medicine 67 (6), 943-94912019
Sodium zirconium cyclosilicate among individuals with hyperkalemia: a 12-month phase 3 studyBS Spinowitz, S Fishbane, PE Pergola, SD Roger, EV Lerma, J Butler, …Clinical Journal of the American Society of Nephrology 14 (6), 798-809882019
Reply: Clinical Context of Dyskalemias Across the Heart Failure Spectrum and Their Associated Adverse OutcomesG Savarese, LH Lund, JJ CarreroJACC: Heart Failure 7 (6), 533-53412019
Arterial stiffness in the heart disease of CKDL Zanoli, P Lentini, M Briet, P Castellino, AA House, GM London, …Journal of the American Society of Nephrology 30 (6), 918-928632019
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceAA House, C Wanner, MJ Sarnak, IL Piña, CW McIntyre, P Komenda, …Kidney international 95 (6), 1304-13171142019
Common laboratory parameters as indicators of multi‐organ dysfunction in acute heart failureS Sudhakaran, PA McCulloughEuropean journal of heart failure 21 (6), 751-7532019
Development and initial validation of the PROMIS®-Plus-HF profile measureFS Ahmad, MA Kallen, KE Schifferdecker, KL Carluzzo, SE Yount, …Circulation: Heart Failure 12 (6), e005751172019
Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson’s DiseasePA McCulloughCardiology and therapy 8 (1), 145-15032019
PCV53 THERAPEUTIC INTENSITY ALGORITHM IS ASSOCIATED WITH ANNUAL EXPENDITURES IN MEDICALLY MANAGED INCIDENT HEART FAILURE PATIENTS WITH AND WITHOUT MITRAL REGURGITATIONJ Van Houten, D Cork, H Mehta, C Barker, P Verta, C Gunnarsson, …Value in Health 22, S128-S1292019
Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategiesJ Rangaswami, RO Mathew, R Parasuraman, E Tantisattamo, M Lubetzky, …Nephrology Dialysis Transplantation 34 (5), 760-773602019
American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal syndrome: classification, pathophysiology, diagnosis …J Rangaswami, V Bhalla, JEA Blair, TI Chang, S Costa, KL Lentine, …Circulation 139 (16), e840-78792019
Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart AssociationJ Rangaswami, V Bhalla, JEA Blair, TI Chang, S Costa, KL Lentine, …Circulation 139 (16), e840-e8783062019
Therapeutic Intensity in Medically Managed Incident Heart Failure Patients with and without Mitral Regurgitation: A Claims Based AnalysisPA McCullough, DP Cork, HS Mehta, CM Barker, C Gunnarsson, M Ryan, …Circulation: Cardiovascular Quality and Outcomes 12 (Suppl_1), A151-A1512019
THE HEALTHCARE BURDEN OF DISEASE PROGRESSION IN MEDICARE PATIENTS WITH FUNCTIONAL MITRAL REGURGITATIONCM Barker, J Van Houten, H Mehta, D Cork, C Gunnarsson, S Mollenkopf, …Journal of the American College of Cardiology 73 (9S1), 1051-10512019
SUPERIOR SINUS VENOSUS DEFECT AND PERSISTENT LEFT-SIDED SUPERIOR VENA CAVA WITH RIGHT HEART ENLARGEMENT IN AN ASYMPTOMATIC MIDDLE-AGED WOMANA Lee, A Afzal, C Barbin, Z Rosol, A Cedars, H Wang, D Lofthus, A Rafael, …Journal of the American College of Cardiology 73 (9S1), 2513-25132019
THE IMPACT OF PREOPERATIVE LENGTH OF STAY ON MAJOR ADVERSE RENAL AND CARDIAC EVENTSKM Tecson, KR Wheelan, P McCulloughJournal of the American College of Cardiology 73 (9S1), 74-742019
THE ECONOMIC IMPACT OF MITRAL REGURGITATION ON MEDICALLY MANAGED INCIDENT HEART FAILURE PATIENTSDP Cork, H Mehta, C Barker, P Verta, C Gunnarsson, MP Ryan, ER Baker, …Journal of the American College of Cardiology 73 (9S1), 1130-11302019
THE IMPACT OF MITRAL REGURGITATION ON MORTALITY AND HEART FAILURE ADMISSIONS IN NEWLY DIAGNOSED HEART FAILURE PATIENTSDP Cork, H Mehta, C Barker, P Verta, MP Ryan, E Baker, C Gunnarsson, …Journal of the American College of Cardiology 73 (9S1), 1131-11312019
Safety and Efficacy of Sodium Zirconium Cyclosilicate for Long-Term Treatment of Hyperkalemia in Patients With Chronic Kidney Disease: Results From an Open-Label, Phase 3 StudyS Roger, P Lavin, E Lerma, PA McCullough, J Butler, B Spinowitz, …NEPHROLOGY NURSING JOURNAL 46 (2), 241-2412019
Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular proceduresPA McCullough, TM Todoran, ES Brilakis, MP Ryan, C GunnarssonCatheterization and Cardiovascular Interventions 93 (2), E90-E9722019
Frequency of abnormal fractional flow reserve measurements among major coronary arteriesCM Barbin, A Vasudevan, JW Choi, PA McCullough, JM Schussler, …Cardiovascular Revascularization Medicine 20 (2), 143-14612019
Comparison of reflex, resistance training, and core activities using change in blood pressure over time after spontaneous coronary artery dissectionK Brown, J Adams, PA McCulloughBaylor University Medical Center Proceedings 32 (1), 113-11512019
Cardiovascular disease in patients with chronic kidney diseasePA McCullough, AY KlugerHypertension 5 (1)12019
Serial urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 and the prognosis for acute kidney injury over the course of critical …PA McCullough, M Ostermann, LG Forni, A Bihorac, JL Koyner, …Cardiorenal medicine 9 (6), 358-36992019
Statin Update: Intolerance, Benefit, and BeyondAY Kluger, KM Tecson, S Sudhakaran, J Zhang, PA McCulloughHypertension 5 (1), 32019
In-hospital mortality and major adverse cardiovascular events after kidney transplantation in the United StatesA Goyal, K Chatterjee, RO Mathew, MS Sidhu, S Bangalore, …Cardiorenal medicine 9 (1), 51-60162019
Effects of bardoxolone methyl on magnesium in patients with type 2 diabetes mellitus and chronic kidney diseaseDV Rizk, AL Silva, PE Pergola, R Toto, DG Warnock, MP Chin, …Cardiorenal medicine 9 (5), 316-32542019
Cardiometabolic-renal disease in South Asians: consensus recommendations from the Cardio Renal Society of AmericaK Vijayaraghavan, PA McCullough, B Singh, M Gupta, E Enas, V Mohan, …Cardiorenal medicine 9 (4), 240-25122019
Community-acquired acute kidney injury as a risk factor of de novo heart failure hospitalizationKM Tecson, H Hashemi, A Afzal, TA Gong, P Kale, PA McCulloughCardiorenal medicine 9 (4), 252-26042019
Key Updates in Cardio-Nephrology from 2018: Springboard to a Bright FutureJ Rangaswami, S Soman, PA McCulloughCardiorenal medicine 9 (4), 222-22822019
Acute Kidney Injury in Heart FailurePA McCullough, C RoncoCritical Care Nephrology, 257-263. e12019
Heart-Kidney Cross-TalkPA McCullough, C RoncoCritical Care Nephrology, 664-670. e32019
Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agentsVH Haase, GM Chertow, GA Block, PE Pergola, EM deGoma, Z Khawaja, …Nephrology Dialysis Transplantation 34 (1), 90-99572019
Cardiorenal Syndrome Type 5C Ronco, L Di Lullo, A BellasiCritical Care Nephrology, 704-711. e22019
Key updates in Cardio-Nephrology from 2018: springboard to a bright FutureJ Rangaswami, S Soman, PA McCulloughReviews in cardiovascular medicine 19 (4), 113-11652018
Variations in the management of significant polyps and early colorectal cancer: results from a multicentre observational study of 383 patientsM Dattani, S Crane, NJ Battersby, F Di Fabio, BP Saunders, S Dolwani, …Colorectal Disease 20 (12), 1088-1096122018
Heart failure in end-stage kidney disease: pathophysiology, diagnosis, and therapeutic strategiesJ Rangaswami, PA McCulloughSeminars in nephrology 38 (6), 600-617282018
Analysis of electrocardiographic intervals before and after transcatheter aortic valve implantation to predict the need for permanent pacingTN Ball, A Vasudevan, J Mi Ko, MD Assar, PA McCullough, RC StolerBaylor University Medical Center Proceedings 31 (4), 407-41342018
Prognostic value of urinary 11‐dehydro‐thromboxane B2 for mortality: A cohort study of stable coronary artery disease patients treated with aspirinA Vasudevan, KM Tecson, J Bennett‐Firmin, T Bottiglieri, LR Lopez, …Catheterization and Cardiovascular Interventions 92 (4), 653-65842018
Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directionsS Sudhakaran, T Bottiglieri, KM Tecson, AY Kluger, PA McCulloughReviews in cardiovascular medicine 19 (3), 77-88172018
Systemic HypertensionR Ochoa-Jimenez, K Viquez-Beita, C Daluwatte, R Zusterzeel, T Ajam, …The American Journal of Cardiology 122 (6)2018
Renal function and exercise training in ambulatoryheart failure patients with a reduced ejection fractionAP Ambrosy, H Mulder, A Coles, WE Krauss, CSP Lam, PA McCullough, …The American journal of cardiology 122 (6), 999-100742018
Cardiorenal Syndrome: A Call to Action for a Pressing Medical IssuePA McCullough, S SomanAdvances in chronic kidney disease 25 (5), 379-38112018
Effects of sodium glucose co-transporter 2 inhibitors on the kidneyN de Albuquerque Rocha, IJ Neeland, PA McCullough, RD Toto, …Diabetes and Vascular Disease Research 15 (5), 375-386292018
Semaglutide and GLP-1 analogues as weight-loss agentsAY Kluger, PA McCulloughLancet (London, England) 392 (10148), 615-61652018
Usefulness of oral ferric citrate in patients with iron-deficiency anemia and chronic kidney disease with or without heart failurePA McCullough, K Uhlig, JF Neylan, PE Pergola, S FishbaneThe American journal of cardiology 122 (4), 683-68882018
Association of urinary 11-dehydro-thromboxane B2 and F2-isoprostanes with mortality in aspirin-treated stable coronary artery disease patientsL Lopez, K Dier, A Vasudevan, T Bottiglieri, P McCulloughAtherosclerosis 275, e882018
Identifying suspected familial chylomicronemia syndromeR Rengarajan, PA McCullough, A Chowdhury, KM TecsonBaylor University Medical Center Proceedings 31 (3), 284-28862018
Frequency of atrial arrhythmias after atrial flutter ablation and the effect of presenting rhythm on the day of ablationA Vasudevan, A Hundae, D Borodge, PA McCullough, PJ WellsBaylor University Medical Center Proceedings 31 (3), 280-28322018
Inhibition of the sodium–proton antiporter (Exchanger) is a plausible mechanism of potential benefit and harm for drugs designed to block sodium glucose co-transporter 2PA McCullough, AY Kluger, KM Tecson, CM Barbin, AY Lee, EV Lerma, …Reviews in cardiovascular medicine 19 (2), 51-63232018
Cardiorenal outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME trials: a systematic reviewAY Kluger, KM Tecson, CM Barbin, AY Lee, EV Lerma, ZP Rosol, …Reviews in cardiovascular medicine 19 (2), 41-49282018
Bioimpedance-guided hydration for the prevention of contrast-induced kidney injury: the HYDRA studyM Maioli, A Toso, M Leoncini, N Musilli, G Grippo, C Ronco, …Journal of the American College of Cardiology 71 (25), 2880-2889412018
Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conferenceMP Turakhia, PJ Blankestijn, JJ Carrero, CM Clase, R Deo, CA Herzog, …European heart journal 39 (24), 2314-23251322018
Robertsonian Perspectives on Atherosclerosis: The Power of Direct ObservationPA McCulloughAmerican Journal of Cardiology 121 (11), 14412018
Major adverse renal and cardiac events after coronary angiography and cardiac surgeryKM Tecson, D Brown, JW Choi, G Feghali, GV Gonzalez-Stawinski, …The Annals of thoracic surgery 105 (6), 1724-1730152018
Cardiovascular risk reduction in patients with chronic kidney disease: potential for targeting inflammation with canakinumabDZI Cherney, Y Lytvyn, PA McCulloughJournal of the American College of Cardiology 71 (21), 2415-241872018
Patterns of kidney function decline in autosomal dominant polycystic kidney disease: a post hoc analysis from the HALT-PKD trialsGM Brosnahan, KZ Abebe, CG Moore, FF Rahbari-Oskoui, KT Bae, …American Journal of Kidney Diseases 71 (5), 666-676262018
FP804 TWO-YEAR DURABILITY OF IMPROVEMENTS IN EGFR WITH BARDOXOLONE METHYL IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: THE LARIAT STUDYC Meyer, M Chakinala, M Chin, D Coyne, J Feldman, A Goldsberry, …Nephrology Dialysis Transplantation 33 (suppl_1), i634-i6342018
SP421 SODIUM ZIRCONIUM CYCLOSILICATE FOR HYPERKALAEMIA IN PATIENTS WITH DIABETES MELLITUS: RETROSPECTIVE ANALYSIS OF A 12 MONTH OPEN LABEL, PHASE 3 STUDYS Fishbane, S Roger, D Packham, P Lavin, S Adler, E Lerma, J Butler, …Nephrology Dialysis Transplantation 33 (suppl_1), i489-i49032018
FP152 EFFECT OF BARDOXOLONE METHYL TREATMENT ON URINARY ALBUMIN IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE-POST-HOC ANALYSIS FROM BEAM AND BEACONP Rossing, G Block, G Chertow, M Chin, A Goldsberry, P McCullough, …Nephrology Dialysis Transplantation 33 (suppl_1), i27-i2712018

Síguenos en nuestro Canal de Telegram

La mejor manera de enterarte de las iniciativas que desde Freenoticias vamos a ir impulsando. Conferencias, debates, nuevos colaboradores, convocatorias. Esto solo ha empezado y este medio libertario va a por todas.

Homo Correctensis. El primer libro de Freenoticias

Un libro que desintegra, fulmina y aplasta todos los iconos y los dogmas de la fe correctensis, empleando cosas absolutamente fachas como el sarcasmo, el humor y los datos. No hay misericordia ni respeto en las páginas de Homo Correctensis, sino un análisis brutalmente directo y sin concesiones, repleto de argumentos, información contrastada y un humor desinfectante.

Dejar respuesta

Please enter your comment!
Please enter your name here

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

ACEPTAR
Aviso de cookies